Peritoneal dialysis (PD) is a vital treatment for end-stage renal disease patients, but its efficacy is often compromised by complications such as infections and peritoneal fibrosis. Biological field-effect transistors (BioFETs) present a promising solution for rapid, sensitive, and non-invasive detection of indicators and biomarkers associated with these complications, potentially enabling early intervention. However, BioFETs are yet to be adopted for PD monitoring. This review presents a forward-looking analysis of the capacity and potential integration of BioFETs into PD management systems, highlighting their capacity to monitor both routine indicators of dialysis efficiency and metabolic status, as well as specific biomarkers for complications such as inflammation and fibrosis. We examine the challenges in adapting BioFETs for PD applications, focusing on key areas for improvement, including sensitivity, specificity, stability, reusability, and clinical integration. Furthermore, we discuss various approaches to address these challenges, which are crucial for developing point-of-care (PoC) and multiplexed wearable devices. These advancements could facilitate continuous, precise, and user-friendly monitoring, potentially revolutionizing PD complication management and enhancing patient care.
The Versatility of Biological Field-Effect Transistor-Based Biosensors (BioFETs) in Point-of-Care Diagnostics: Applications and Future Directions for Peritoneal Dialysis Monitoring
Quan Wang,Zian Zhao,Keyu Yao,Yuk-lun Cheng,D. Wong,Duo Wai-Chi Wong,James Siu Wai Cheung
Published 2025 in Biosensors
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Biosensors
- Publication date
2025-03-01
- Fields of study
Biology, Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-4 of 4 citing papers · Page 1 of 1